SXTC | tickerfilter.com

Fundamental analysis

33%

Profitability 44%

Dept financing 15%

Liquidity 43%

Performance 23%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-9.21%

1 Month

-47.46%

3 Months

44.76%

6 Months

50.00%

1 Year

-55.86%

2 Year

6.70%

Key data

Stock price

$2.07

P/E Ratio

0.00

DAY RANGE

$2.00 - $2.16

EPS

N/A

52 WEEK RANGE

$0.03 - $6.98

52 WEEK CHANGE

-$58.64

MARKET CAP

2.185 M

YIELD

N/A

SHARES OUTSTANDING

3.476 M

DIVIDEND

$0.00

EX-DIVIDEND DATE

02-25-2025

NEXT EARNINGS DATE

N/A

BETA

2.23

PUBLIC FLOAT

AVERAGE 10 VOLUME

$49,577

AVERAGE 30 VOLUME

$32,937,240

Company detail

CEO: Feng Zhou
Region: US
Website: sxtchina.com
Employees: 90
IPO year: 2019

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

China SXT Pharmaceuticals, Inc. engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company was founded in 2005 and is based in Taizhou, China.

SXTC - China SXT Pharmaceuticals, Inc.